BioCentury | Apr 6, 2015
Company News

Hyperion Therapeutics Inc, Horizon Pharma deal

...worldwide rights to the pre-prodrug of phenylacetic acid from the Ucyclyd Pharma Inc. subsidiary of Medicis Pharmaceutical...
BioCentury | Oct 20, 2014
Company News

Coronado Biosciences management update

...Medical Corp. subsidiary, formerly VP of dermatology sales and executive director of aesthetics sales at Medicis Pharmaceutical...
BioCentury | Oct 20, 2014
Company News

Coronado Biosciences dermatology news

...subsidiary. Maraoui is formerly VP of dermatology sales and executive director of aesthetics sales at Medicis Pharmaceutical...
BioCentury | Aug 11, 2014
Clinical News

Ravicti glycerol phenylbutyrate regulatory update

...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of Medicis Pharmaceutical...
BioCentury | Aug 11, 2014
Clinical News

Gazyva regulatory update

...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of Medicis Pharmaceutical...
BioCentury | Aug 4, 2014
Company News

Ipsen, Nestle deal

...U.S. and Canadian rights to commercialize Dysport, which Valeant gained in its 2012 acquisition of Medicis Pharmaceutical...
BioCentury | Aug 4, 2014
Company News

Cosmo Pharmaceuticals S.p.A., Valeant Pharmaceuticals deal

...Cosmo and Valeant amended an April 2012 deal that granted Medicis Pharmaceutical Corp. , now part of...
BioCentury | Jun 30, 2014
Clinical News

Ravicti glycerol phenylbutyrate regulatory update

...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of Medicis Pharmaceutical...
BioCentury | Jun 16, 2014
Finance

Biotech rating scheme

...devices, with expertise that includes trial design. 2004-07: VP clinical research and regulatory affairs for Medicis Pharmaceutical...
BioCentury | Jun 2, 2014
Company News

Valeant Pharmaceuticals, Nestle deal

...U.S. and Canadian rights to commercialize several products Valeant gained in its 2012 acquisition of Medicis Pharmaceutical...
Items per page:
1 - 10 of 150
BioCentury | Apr 6, 2015
Company News

Hyperion Therapeutics Inc, Horizon Pharma deal

...worldwide rights to the pre-prodrug of phenylacetic acid from the Ucyclyd Pharma Inc. subsidiary of Medicis Pharmaceutical...
BioCentury | Oct 20, 2014
Company News

Coronado Biosciences management update

...Medical Corp. subsidiary, formerly VP of dermatology sales and executive director of aesthetics sales at Medicis Pharmaceutical...
BioCentury | Oct 20, 2014
Company News

Coronado Biosciences dermatology news

...subsidiary. Maraoui is formerly VP of dermatology sales and executive director of aesthetics sales at Medicis Pharmaceutical...
BioCentury | Aug 11, 2014
Clinical News

Ravicti glycerol phenylbutyrate regulatory update

...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of Medicis Pharmaceutical...
BioCentury | Aug 11, 2014
Clinical News

Gazyva regulatory update

...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of Medicis Pharmaceutical...
BioCentury | Aug 4, 2014
Company News

Ipsen, Nestle deal

...U.S. and Canadian rights to commercialize Dysport, which Valeant gained in its 2012 acquisition of Medicis Pharmaceutical...
BioCentury | Aug 4, 2014
Company News

Cosmo Pharmaceuticals S.p.A., Valeant Pharmaceuticals deal

...Cosmo and Valeant amended an April 2012 deal that granted Medicis Pharmaceutical Corp. , now part of...
BioCentury | Jun 30, 2014
Clinical News

Ravicti glycerol phenylbutyrate regulatory update

...HE). Hyperion has worldwide rights to the product from Ucyclyd Pharma Inc., a subsidiary of Medicis Pharmaceutical...
BioCentury | Jun 16, 2014
Finance

Biotech rating scheme

...devices, with expertise that includes trial design. 2004-07: VP clinical research and regulatory affairs for Medicis Pharmaceutical...
BioCentury | Jun 2, 2014
Company News

Valeant Pharmaceuticals, Nestle deal

...U.S. and Canadian rights to commercialize several products Valeant gained in its 2012 acquisition of Medicis Pharmaceutical...
Items per page:
1 - 10 of 150